These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31221667)

  • 21. Incremental cost-effectiveness of initial cataract surgery.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2002 Mar; 109(3):606-12; discussion 612-3. PubMed ID: 11874769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-utility of routine cataract surgery.
    Räsänen P; Krootila K; Sintonen H; Leivo T; Koivisto AM; Ryynänen OP; Blom M; Roine RP
    Health Qual Life Outcomes; 2006 Sep; 4():74. PubMed ID: 17010185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis.
    Brown GC; Brown MM; Chaudhry I; Stein JD
    JAMA Ophthalmol; 2021 Apr; 139(4):389-397. PubMed ID: 33538789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of femtosecond laser-assisted cataract surgery versus phacoemulsification cataract surgery.
    Abell RG; Vote BJ
    Ophthalmology; 2014 Jan; 121(1):10-16. PubMed ID: 24120324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
    Jaine R; Kvizhinadze G; Nair N; Blakely T
    Lung Cancer; 2020 Jun; 144():99-106. PubMed ID: 32317183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term cost-effectiveness analysis of rugby fans in training-New Zealand: a body weight reduction programme for males.
    Lee P; Hargreaves E; Jiang Y; Calder A; Marsh S; Gray C; Hunt K; Eyles H; Draper N; Heke I; Kara S; Maddison R; Gao L
    BMJ Open; 2024 Jul; 14(7):e073740. PubMed ID: 39043600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study.
    ; Hiratsuka Y; Yamada M; Akune Y; Murakami A; Okada AA; Yamashita H; Ohashi Y; Yamagishi N; Tamura H; Fukuhara S; Takura T
    Jpn J Ophthalmol; 2013 Jul; 57(4):391-401. PubMed ID: 23588297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk.
    Nghiem N; Knight J; Mizdrak A; Blakely T; Wilson N
    Sci Rep; 2019 Dec; 9(1):19562. PubMed ID: 31862895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial).
    Cockayne S; Rodgers S; Green L; Fairhurst C; Adamson J; Scantlebury A; Corbacho B; Hewitt CE; Hicks K; Hull R; Keenan AM; Lamb SE; McIntosh C; Menz HB; Redmond A; Richardson Z; Vernon W; Watson J; Torgerson DJ
    Health Technol Assess; 2017 Apr; 21(24):1-198. PubMed ID: 28621259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of a group-based exercise program for falls prevention among the older community-dwelling population.
    McLean K; Day L; Dalton A
    BMC Geriatr; 2015 Mar; 15():33. PubMed ID: 25879871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Country-level Health and Cost Impacts of Legalizing Domestic Sale of Vaporized Nicotine Products.
    Petrović-van der Deen FS; Wilson N; Crothers A; Cleghorn CL; Gartner C; Blakely T
    Epidemiology; 2019 May; 30(3):396-404. PubMed ID: 30789423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-utility analysis of cataract surgery in the United States for the year 2018.
    Brown GC; Brown MM; Busbee BG
    J Cataract Refract Surg; 2019 Jul; 45(7):927-938. PubMed ID: 31262482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can cost-effectiveness results be combined into a coherent league table? Case study from one high-income country.
    Wilson N; Davies A; Brewer N; Nghiem N; Cobiac L; Blakely T
    Popul Health Metr; 2019 Aug; 17(1):10. PubMed ID: 31382954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing Smartphone Apps for Physical Activity Promotion in Primary Care: Modeling Study of Health Gain and Cost Savings.
    Grout L; Telfer K; Wilson N; Cleghorn C; Mizdrak A
    J Med Internet Res; 2021 Dec; 23(12):e31702. PubMed ID: 34931993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost effectiveness of universal antenatal screening for HIV in New Zealand.
    Bramley D; Graves N; Walker D
    AIDS; 2003 Mar; 17(5):741-8. PubMed ID: 12646798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of a Multifaceted Podiatry Intervention for the Prevention of Falls in Older People: The REducing Falls with Orthoses and a Multifaceted Podiatry Intervention Trial Findings.
    Corbacho B; Cockayne S; Fairhurst C; Hewitt CE; Hicks K; Kenan AM; Lamb SE; MacIntosh C; Menz HB; Redmond AC; Rodgers S; Scantlebury A; Watson J; Torgerson DJ;
    Gerontology; 2018; 64(5):503-512. PubMed ID: 29945150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health Benefits and Cost-Effectiveness From Promoting Smartphone Apps for Weight Loss: Multistate Life Table Modeling.
    Cleghorn C; Wilson N; Nair N; Kvizhinadze G; Nghiem N; McLeod M; Blakely T
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e11118. PubMed ID: 30664471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated Health and Cost Impacts of Electronic Nicotine Delivery Systems, Using Recent Estimates of Relative Harm for Vaping Compared to Smoking.
    Summers JA; Ait Ouakrim D; Wilson N; Blakely T
    Nicotine Tob Res; 2022 Feb; 24(3):408-412. PubMed ID: 34570237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer care coordinators in stage III colon cancer: a cost-utility analysis.
    Blakely T; Collinson L; Kvizhinadze G; Nair N; Foster R; Dennett E; Sarfati D
    BMC Health Serv Res; 2015 Aug; 15():306. PubMed ID: 26238996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.